ArticleCureus2024

Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy.

Goncagul Akdag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.